Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery

Rheumatology International

Volumn 26, Issue 12, 2006, Pages 1138-1142

  Fuerst, Martin ^a,b   Möhl, Henrike ^a,b   Baumgärtel, Kerstin ^a,b   Rüther, Wolfgang ^a,b  

^a Rheumaklinik Bad Bramstedt ^*  (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Orthopedic surgery; Rheumatoid arthritis; Wound healing

Indexed keywords

ADALIMUMAB; COLESTYRAMINE; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANKLE ARTHRODESIS; ARTHROPLASTY; ARTICLE; ELECTIVE SURGERY; FEMALE; FOOT SURGERY; HALLUX VALGUS; HAND SURGERY; HEALING IMPAIRMENT; HIP SURGERY; HUMAN; INCIDENCE; INFECTION; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REOPERATION; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; RISK REDUCTION; SHOULDER INJURY; SURGICAL RISK; SYNOVECTOMY; TISSUE NECROSIS; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMBINED MODALITY THERAPY; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; ORTHOPEDICS; POSTOPERATIVE COMPLICATIONS; RISK; SURGICAL WOUND INFECTION; WOUND HEALING;

EID: 33749039943     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0138-z     Document Type: Article

References (9)

1. Cronstein BN (1996) Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 39:1951-1960
2. Bridges S, Lopez Mendez A, Han K, Tracy F, Alarson G (1991) Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 18:984-988
3. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Ann Rheum Dis 60:214-217
4. Fox RI, Herrmann ML, Fangou CG, Wahl GM, Morris RE, Strand V et al (1999) Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 93:198-208
5. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G et al (1999) Treatment of active rheumatoid arthritis with leflunomidee compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 159:2542-2550
6. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A et al (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double blind, randomised, multicenter trial. European Leflunomidee Study Group. Lancet 353:259-266
7. Talwalkar SC, Grennan DM, Gray J, Johnson P, Hayton MJ (2005) Tumor necrosis factor α antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopedic surgery. Ann Rheum Dis 64:650-651
8. Bibbo C, Goldberg JW (2004) Infectious and healing complications after elective orthopedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25(5):331-335
9. Schrieber S, Campieri M, Colombel JF, van Deventer SJH, Feagan B, Fedorak R et al (2001) Use of anti-tumor necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int Colorectal Dis 16:1-11